IHF:NYE-iShares U.S. Healthcare Providers ETF (USD)

ETF | Health |

Last Closing

USD 53.26

Change

-0.96 (-1.77)%

Market Cap

N/A

Volume

0.06M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-14 )

Largest Industry Peers for Health

Symbol Name Price(Change) Market Cap
XLV Health Care Select Sector SPDR..

-2.31 (-1.57%)

USD 40.46B
FHLC Fidelity® MSCI Health Care In..

-1.17 (-1.67%)

USD 2.91B
FXH First Trust Health Care AlphaD..

-2.16 (-1.94%)

USD 1.19B
XHE SPDR® S&P Health Care Equipme..

-1.78 (-1.96%)

USD 0.22B
IDNA iShares Genomics Immunology an..

-0.66 (-2.70%)

USD 0.15B
SBIO ALPS Medical Breakthroughs ETF

-1.18 (-2.93%)

USD 0.13B
XHS SPDR® S&P Health Care Service..

-2.68 (-2.80%)

USD 0.08B
HTEC Robo Global® Healthcare Techn..

-0.79 (-2.68%)

USD 0.06B
BBP Virtus LifeSci Biotech Product..

-1.78 (-2.73%)

USD 0.02B
BBC Virtus LifeSci Biotech Clinica..

-0.93 (-3.17%)

USD 0.01B

ETFs Containing IHF

MSSS 9.54 % 0.00 %

N/A

N/A
LCR Leuthold Core ETF 0.00 % 0.00 %

-0.10 (0%)

USD 0.09B

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.43% 5% F 34% F
Dividend Return 0.58% 50% F 8% B-
Total Return 2.01% 5% F 25% F
Trailing 12 Months  
Capital Gain 5.64% 5% F 34% F
Dividend Return 0.81% 50% F 8% B-
Total Return 6.44% 5% F 25% F
Trailing 5 Years  
Capital Gain 39.54% 67% D+ 66% D+
Dividend Return 5.40% 56% F 13% F
Total Return 44.94% 62% D 61% D-
Average Annual (5 Year Horizon)  
Capital Gain 6.69% 67% D+ 58% F
Dividend Return 7.32% 67% D+ 53% F
Total Return 0.62% 63% D 15% F
Risk Return Profile  
Volatility (Standard Deviation) 21.44% 43% F 51% F
Risk Adjusted Return 34.12% 57% F 51% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.